Table 1.

Summary of significant potential health benefits of fish consumption in previous meta-analysis.

References	Studies (N)	Participants (n)	Outcome	RR (95% Cl)/SRR *
Jayedi et al. (2018) [79]	14	911,348	All-cause mortality	0.97 (0.96–0.98)
Djousse et al. (2012) [80]	5	170,131	Heart failure	0.95 (0.93–0.98)
Zhao et al. (2016) [81]	12	672,389	All-cause mortality	0.94 (0.90–0.98)
Kim et al. (2015) [84]	9	7860	Metabolic syndrome	0.71 (0.58–0.87)
Muley et al. (2014) [85]	16	679,763	T2DM	0.89 (0.801–0.987)
Kolahdooz et al. (2010) [86]	6	16,886	Ovarian cancer	0.84 (0.68–1.03)
Bandera et al. (2007) [88]	5	10,543	Endometrial cancer	1.88 (1.20–2.98)
Wu et al. (2016) [89]	13	758,359	Breast cancer	1.07 (0.94–1.21)
Zheng et al. (2013) [90]	11	687,770	Breast cancer	1.03 (0.93–1.14)
Wu et al. (2016) [91]		52,683	Prostate cancer	1.04 (0.98–1.09)
Szymański et al. (2010) [92]		49,661	Prostate cancer	0.37 (0.18–0.74)
Vieira et al. (2017) [93]	11	3944	Colorectal cancer	0.89 (0.80–0.99)
Zhang et al. (2016) [94]	4	21,099	Dementia	0.95 (0.90–0.99)
	5	21,941	Alzheimer’s disease	0.93 (0.90–0.95)
Jayedi et al. (2020) [95]	38	153,998	All-cause mortality	0.92 * (0.87–0.97)
	8	11,720	Cardiovascular mortality	0.75 * (0.65–0.87)
	22	16,732	Coronary heart disease	0.88 * (0.79–0.99)
	11	8468	Myocardial infarction	0.75 * (0.65–0.93)
	20	14,360	Stroke	0.86 * (0.75–0.99)
	8	7945	Heart failure	0.80 * (0.67–0.95)
	8	5732	Depression	0.88 * (0.79–0.98)
	5	1572	Liver cancer	0.65 * (0.48–0.87)

* SRR—summary relative risk. Type 2 Diabetes Mellitus (T2DM).